hg_228558.1

Basic information about the TSS

---

TSS ID: hg_228558.1 Species: human Chr: chr22		Start: 38272927 End: 38272940 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000411679.2 CR749859 Distance: 0 GeneID: 25829 HGNC/MGI_ID: HGNC:1310 UniProt_ID: F2Z397

Gene_name: transmembrane protein 184B Gene_symbol: TMEM184B Gene_synonyms: DKFZP586A1024 FM08 HS5O6A Gene_source: HGNC:1310

TATA-Box annotation

---

Distance to TSS:	76
Nearest PromoterID:	NM_001195072
Entrez ID:	25829
Nearest Unigene:	Hs.182626
Nearest Refseq:	NM_012264
Nearest Ensembl:	ENSG00000198792
Gene Name:	transmembrane protein 184B
Gene Alias:	C22orf5|FM08|HS5O6A|HSPC256
Gene Description:	transmembrane protein 184B
Gene Type:	protein-coding
CpG%:	0.16
GC%:	0.800995
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMEM184B p2@TMEM184B p4@TMEM184B p5@TMEM184B p6@TMEM184B
Sample		p1@TMEM184B	p2@TMEM184B	p4@TMEM184B	p5@TMEM184B	p6@TMEM184B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	23.77	2.73	0.39	0.58	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	27.92	3.24	0.40	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.62	3.47	0.00	0.19	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.87	2.70	0.21	0.83	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.47	2.47	0.00	0.67	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	19.38	3.29	0.19	0.58	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	29.41	4.36	0.65	0.22	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	25.43	3.15	0.48	0.24	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.35	5.13	0.64	1.07	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.61	3.48	0.00	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.21	3.23	0.40	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.86	4.47	0.81	1.22	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	30.63	2.58	1.93	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.56	1.80	0.75	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	29.86	3.73	0.66	0.66	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	22.13	2.51	0.50	0.75	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	23.81	3.28	0.66	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.83	3.37	1.27	1.27	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	2.67	0.00	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	31.74	2.11	1.20	0.60	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.40	1.07	0.94	0.40	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	24.86	0.86	1.21	0.69	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.95	1.42	1.16	0.39	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.35	2.43	0.73	1.21	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.41	1.29	0.52	1.29	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	28.17	1.90	0.63	0.63	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.57	0.55	1.10	2.75	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.01	2.59	2.36	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	29.72	2.10	0.65	0.81	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.97	2.53	0.72	0.90	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.19	2.51	1.26	0.84	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	29.31	1.95	1.37	0.98	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.33	1.90	1.27	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.82	1.98	0.33	0.33	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	27.67	1.87	0.56	1.50	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	33.53	1.92	1.34	1.15	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	25.75	1.43	1.84	0.82	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	28.81	2.82	0.60	0.40	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.04	4.05	1.62	1.35	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.45	2.64	0.96	0.96	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	26.82	1.88	0.94	1.41	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.08	0.88	1.32	0.73	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	27.84	1.48	0.84	1.27	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.99	2.62	1.75	1.40	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	28.51	1.61	0.80	1.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	25.82	2.33	1.63	1.16	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	30.71	2.40	0.72	0.72	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	22.06	3.58	2.09	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	36.38	4.07	1.44	1.68	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.53	3.44	0.81	0.40	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.92	3.69	1.02	0.61	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	38.47	3.78	1.11	1.11	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	32.29	4.26	0.71	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.14	4.64	1.66	0.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.91	0.00	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.29	3.21	0.92	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	36.30	3.89	1.30	0.00	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	43.04	5.14	1.93	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.89	2.20	0.31	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.71	7.05	0.71	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.94	5.05	1.12	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	17.52	0.00	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	20.39	1.02	0.00	0.00	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	44.84	6.17	2.27	1.62	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	42.95	5.68	0.71	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	44.85	5.36	2.44	2.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	49.59	6.94	3.97	0.50	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	36.12	5.63	2.81	2.81	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	32.13	2.32	2.65	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	49.19	4.02	2.47	1.55	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	50.75	5.81	2.75	1.22	0.31
Adipocyte - breast, donor1	11376-118A8	34.21	5.86	0.95	0.79	1.27
Adipocyte - breast, donor2	11327-117E4	40.43	5.61	2.25	1.28	0.48
Adipocyte - omental, donor1	11473-119C6	41.73	6.49	1.65	1.15	1.15
Adipocyte - omental, donor2	11474-119C7	43.35	7.47	0.00	3.74	0.00
Adipocyte - omental, donor3	11475-119C8	36.84	4.35	1.67	0.67	1.00
Adipocyte - perirenal, donor1	11476-119C9	38.92	2.55	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	31.61	4.52	1.35	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	35.45	2.43	1.39	1.04	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	37.75	5.87	2.35	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	23.68	4.38	1.54	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	24.53	3.07	1.12	1.12	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	31.15	6.47	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	55.18	4.18	1.29	1.53	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	30.98	3.23	0.32	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	30.92	1.60	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	30.60	2.23	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	39.93	2.91	1.66	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	28.88	2.76	1.51	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	25.20	4.25	0.65	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	32.58	5.48	0.91	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	69.61	5.75	1.55	2.21	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	115.82	12.91	5.74	3.23	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	44.33	3.59	0.00	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	54.69	10.61	2.52	1.44	1.98
Amniotic Epithelial Cells, donor2	11613-122A2	40.16	3.35	1.67	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	68.41	9.04	2.26	2.05	1.64
Anulus Pulposus Cell, donor1	11248-116E6	32.73	6.41	0.80	0.23	0.57
Anulus Pulposus Cell, donor2	11463-119B5	45.06	4.90	1.47	0.73	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	47.18	4.04	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	45.58	6.51	1.30	0.87	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	38.52	10.70	0.00	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	43.34	5.08	0.60	2.09	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	50.59	5.06	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	41.58	5.94	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	38.99	2.60	0.65	1.30	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	52.43	3.88	0.00	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	37.41	3.56	0.00	2.38	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	40.68	5.27	0.75	0.38	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	42.81	7.98	0.73	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	32.60	5.02	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	42.83	6.26	0.99	2.31	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	6.82	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	45.54	4.98	1.51	1.21	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	51.97	5.36	1.61	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	45.91	5.48	1.13	1.32	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	39.83	6.15	1.07	0.80	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	24.39	7.80	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	45.45	5.31	2.16	2.16	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	3.60	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	3.54	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	54.55	7.38	2.40	2.40	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	34.47	2.91	0.49	0.97	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	51.61	3.79	1.90	1.90	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	38.76	9.69	1.21	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	34.20	2.85	2.28	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.75	5.77	1.71	0.64	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	36.91	4.13	1.55	2.06	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	45.04	3.28	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	55.31	8.68	0.96	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	37.10	7.85	0.00	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.36	4.68	0.00	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	50.88	6.32	1.51	1.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	47.52	5.94	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	46.28	3.56	1.02	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	50.68	4.33	2.04	2.29	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	33.67	3.18	0.00	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	42.29	5.18	0.43	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	44.03	5.50	1.27	2.54	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	33.35	3.77	0.58	1.16	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	47.24	6.61	0.94	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	47.30	5.09	1.70	2.20	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	48.64	4.63	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	4.23	2.11	4.23	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	51.67	6.22	1.72	1.50	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	34.90	9.02	1.20	0.00	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	48.84	7.29	0.00	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	48.05	4.14	1.61	2.07	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	53.56	10.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	34.07	7.88	1.27	1.02	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	53.05	5.99	0.62	1.45	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	38.86	7.04	3.06	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	47.32	5.26	1.43	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	52.77	5.99	1.55	2.00	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	36.62	10.68	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	36.00	6.09	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	43.69	7.94	1.85	1.85	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	43.98	4.00	1.82	2.54	1.09
Astrocyte - cerebellum, donor1	11500-119F6	63.37	12.77	0.86	0.61	0.86
Astrocyte - cerebellum, donor2	11580-120F5	75.31	13.86	1.37	0.68	0.17
Astrocyte - cerebellum, donor3	11661-122F5	49.92	8.81	1.47	1.68	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	31.37	5.93	2.79	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	43.19	5.50	0.81	1.29	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	58.92	6.56	1.64	1.34	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	8.37	2.29	0.11	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	8.90	2.51	0.00	0.38	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11.61	3.87	0.11	0.00	0.00
Basophils, donor1	12241-129G9	15.95	1.83	0.26	0.00	0.52
Basophils, donor2	12242-129H1	12.99	1.08	0.36	0.00	0.36
Basophils, donor3	12243-129H2	19.84	1.47	0.00	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	26.52	5.39	1.08	1.08	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	82.29	4.57	1.83	1.37	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	45.19	2.51	3.14	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	81.10	5.61	1.46	2.70	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	38.69	1.84	0.69	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	32.39	1.80	1.08	1.62	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.87	3.61	0.31	0.31	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	15.37	4.66	0.23	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	14.07	1.60	0.00	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	16.91	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	16.89	2.23	0.74	0.37	0.56
CD14+ Monocytes, donor3	11381-118B4	20.20	1.98	0.44	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	21.23	1.98	0.57	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	25.02	2.65	0.38	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	20.71	2.96	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	20.24	1.16	0.87	0.58	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	16.60	1.51	0.60	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	20.85	0.95	0.24	0.47	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	16.40	2.18	0.17	0.33	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.56	2.48	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.10	0.50	0.00	0.74	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.73	0.78	0.00	0.78	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.60	2.31	0.18	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	10.01	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.73	0.47	0.00	0.70	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	18.48	1.58	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	17.11	1.19	0.89	0.30	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.57	1.40	0.40	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.95	1.04	0.21	0.83	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.01	1.83	0.23	0.69	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	11.54	1.13	0.00	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.97	0.44	1.75	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.87	1.88	0.54	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	20.06	1.57	0.00	0.35	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	12.20	2.10	0.84	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.47	0.92	0.00	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.27	1.76	0.35	0.00	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	12.28	1.32	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.51	1.22	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.75	0.74	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	10.99	1.72	0.22	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.83	0.82	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.97	0.70	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.50	0.70	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	7.19	0.44	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.47	1.85	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	5.42	1.73	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	17.44	2.18	0.16	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	10.13	1.40	0.00	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	16.72	2.68	0.45	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	5.36	0.77	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.73	1.54	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	3.16	0.84	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.10	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	8.28	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	6.40	3.73	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	9.11	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.06	2.35	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	6.59	2.64	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	9.04	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.25	2.18	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	4.04	1.01	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	5.25	1.21	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.40	0.80	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	3.01	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	21.35	1.69	0.00	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	12.40	4.51	0.00	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	14.88	3.38	0.23	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	21.07	7.86	0.36	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	32.46	9.80	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	22.57	4.88	0.91	0.00	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.40	4.34	1.02	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	17.74	4.04	0.45	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.54	3.74	1.15	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	17.07	3.79	0.47	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.83	0.70	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	6.59	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	21.53	3.76	0.14	0.58	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	28.47	4.58	0.17	0.17	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	23.05	5.80	0.48	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.97	2.24	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	13.63	2.80	0.00	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	11.88	1.76	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.08	5.06	0.00	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.15	3.95	0.21	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.71	2.67	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.85	5.71	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	17.15	5.36	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	3.59	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	27.63	5.93	0.56	0.37	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.13	4.33	0.43	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	28.16	4.83	0.21	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.68	2.02	0.51	0.00	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	19.93	4.77	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.87	2.61	1.31	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	21.77	6.43	0.99	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	4.62	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	6.98	4.19	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	21.60	3.88	0.28	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	27.97	4.91	0.49	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	4.62	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.20	2.15	0.36	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	32.08	3.60	0.33	0.33	1.31
CD8+ T Cells, donor2	11307-117C2	33.04	4.88	0.38	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	35.60	4.54	0.76	0.76	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.93	2.75	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	10.78	3.83	0.24	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.85	1.37	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.61	1.20	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.12	4.08	0.48	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.05	2.05	0.23	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.34	4.35	0.22	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.32	3.16	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.01	3.75	0.23	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.79	2.42	0.30	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	14.82	3.49	0.29	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.52	2.40	0.27	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	16.20	3.06	0.88	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	17.31	2.73	0.46	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	33.56	3.73	1.49	0.00	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.93	6.12	0.36	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.41	4.60	0.29	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.08	5.42	0.71	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	22.50	3.49	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	22.45	5.84	0.31	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.07	4.49	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.21	2.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	15.76	2.36	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	16.64	3.78	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	26.50	2.41	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	0.00	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	31.05	2.00	0.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	21.93	5.48	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	25.69	3.46	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	37.67	3.05	2.21	1.47	1.58
Chondrocyte - de diff, donor1	11261-116G1	58.24	9.01	1.39	1.04	1.04
Chondrocyte - de diff, donor2	11338-117F6	30.21	5.69	2.49	0.36	1.42
Chondrocyte - de diff, donor3	11410-118E6	31.86	4.78	1.71	1.37	1.02
Chondrocyte - re diff, donor2	11339-117F7	40.29	5.37	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	48.12	6.87	3.24	1.21	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	53.59	8.03	0.92	1.49	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	47.67	6.41	1.07	0.86	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	64.07	4.87	2.21	1.59	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	51.26	8.44	1.93	1.38	1.93
Corneal Epithelial Cells, donor1	11526-119I5	46.77	6.81	1.32	0.88	0.88
Corneal Epithelial Cells, donor2	11606-120I4	19.34	4.55	1.14	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	36.81	2.05	1.28	2.05	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.15	2.48	0.17	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	15.77	2.21	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	14.69	2.38	0.54	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	30.75	2.39	0.68	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	23.50	3.26	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	29.04	3.39	0.48	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	45.53	3.50	2.00	2.67	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	37.55	4.11	2.35	2.93	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	81.16	9.62	3.96	1.70	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	48.75	7.86	2.75	3.15	1.18
Endothelial Cells - Artery, donor1	11264-116G4	66.32	4.94	2.33	3.49	0.87
Endothelial Cells - Artery, donor2	11341-117F9	82.11	6.35	4.47	1.65	0.24
Endothelial Cells - Artery, donor3	11413-118E9	68.02	6.84	3.86	3.33	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.00	3.99	1.77	2.66	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	53.86	6.39	1.83	2.43	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	60.33	6.48	2.54	3.66	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	73.39	6.83	0.89	1.19	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	47.90	5.73	1.04	2.60	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	52.89	5.39	3.26	2.98	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	87.63	8.80	0.40	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	64.47	6.29	4.19	2.62	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	58.02	6.46	1.74	0.75	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.06	4.78	1.52	0.87	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	68.51	5.98	2.20	1.22	1.34
Endothelial Cells - Vein, donor1	11267-116G7	63.70	11.38	0.00	0.00	3.41
Endothelial Cells - Vein, donor2	11344-117G3	69.85	7.68	2.79	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	56.21	5.02	1.57	1.41	0.94
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	206.28	4.95	4.95	4.95	3.30
Eosinophils, donor3	12246-129H5	131.97	0.00	0.00	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	36.16	4.15	0.98	1.95	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	2.08	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	57.06	5.34	2.46	3.69	3.28
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	27.92	3.83	1.53	1.64	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	29.47	4.88	1.08	1.52	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	50.45	5.09	1.58	1.46	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.16	4.50	0.96	1.23	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	48.73	7.59	1.48	1.48	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	46.64	5.53	0.79	0.53	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	59.80	8.30	2.33	2.33	2.66
Fibroblast - Cardiac, donor1	11268-116G8	47.63	7.71	1.36	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	73.52	9.85	1.52	5.31	2.27
Fibroblast - Cardiac, donor3	11417-118F4	83.43	8.20	5.05	5.99	2.21
Fibroblast - Cardiac, donor4	11452-119A3	40.62	6.67	0.61	0.91	0.61
Fibroblast - Cardiac, donor5	11456-119A7	50.89	5.08	1.40	1.14	0.76
Fibroblast - Cardiac, donor6	11460-119B2	50.78	5.76	1.52	1.21	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	74.63	15.41	1.21	0.54	1.34
Fibroblast - Choroid Plexus, donor2	11572-120E6	45.73	6.90	1.29	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	39.55	10.25	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	62.96	6.92	1.15	1.15	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	31.89	5.94	1.87	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	27.47	4.23	0.47	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	30.66	2.83	1.89	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	36.02	4.47	0.97	1.33	0.36
Fibroblast - Dermal, donor4	11450-119A1	36.85	6.44	0.57	0.57	0.34
Fibroblast - Dermal, donor5	11454-119A5	41.69	5.23	0.87	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	55.39	8.28	0.65	1.46	0.16
Fibroblast - Gingival, donor1	11237-116D4	53.31	6.87	1.87	1.04	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	83.58	12.58	2.36	1.31	0.79
Fibroblast - Gingival, donor2	11318-117D4	60.36	9.49	2.11	0.79	0.66
Fibroblast - Gingival, donor3	11394-118C8	53.95	5.32	1.74	0.68	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	69.61	9.35	7.27	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	51.80	7.05	1.59	2.11	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	69.53	9.04	1.71	0.62	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	55.04	9.20	1.35	2.16	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	105.51	13.41	2.47	2.12	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	63.32	8.77	1.17	1.46	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	61.90	9.41	0.55	0.55	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	70.09	10.86	1.54	1.76	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	52.24	7.48	1.91	1.47	1.32
Fibroblast - Lung, donor1	11270-116H1	50.30	8.16	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	49.24	8.95	4.48	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	55.29	6.33	1.90	0.42	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	101.63	21.66	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	81.12	9.79	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	43.66	4.20	1.12	1.12	0.56
Fibroblast - Mammary, donor1	11540-120B1	89.72	18.67	4.06	2.44	1.62
Fibroblast - Mammary, donor2	11620-122A9	67.90	7.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	46.36	6.79	0.78	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	63.40	8.80	1.06	1.37	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	78.64	11.93	2.45	1.53	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	60.68	4.20	2.67	0.38	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	50.22	8.37	2.70	0.81	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	66.80	7.42	2.32	2.32	2.09
Fibroblast - Pulmonary Artery, donor1	11250-116E8	49.63	4.53	1.99	1.33	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	117.65	16.86	3.86	3.66	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	71.50	7.35	2.00	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	33.61	6.33	0.00	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	46.64	6.75	0.40	0.79	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	45.47	3.37	1.60	0.53	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	38.04	7.49	1.97	1.38	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	62.58	14.14	0.30	0.30	3.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	56.46	5.51	0.97	0.54	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.57	2.02	0.00	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	47.58	6.07	1.97	1.31	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	65.77	10.03	2.01	1.00	3.81
Fibroblast - skin normal, donor2	11561-120D4	47.32	6.83	0.90	1.31	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.34	7.86	0.30	0.91	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	42.58	6.13	1.08	1.08	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	50.43	5.13	1.88	1.20	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	48.94	8.21	0.00	2.30	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	55.18	5.75	1.38	0.96	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	58.19	9.78	1.35	1.52	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.66	0.63	0.47	0.94	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.92	0.87	0.00	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	57.38	5.37	1.04	2.77	1.73
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	68.70	3.90	2.08	2.08	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	70.27	4.60	1.53	3.58	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	9.95	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.80	3.83	1.28	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	39.37	4.56	0.29	0.86	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	78.32	9.38	1.10	0.55	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	48.41	10.96	0.68	1.14	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	43.19	5.55	1.19	0.79	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	71.63	7.93	0.53	0.79	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	58.05	5.54	1.96	1.30	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	36.70	4.86	1.33	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.33	5.51	0.28	0.85	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	39.77	6.03	2.09	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	35.19	5.10	1.34	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.29	5.33	0.99	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.65	5.68	0.14	0.83	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	27.45	4.07	1.42	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	36.05	8.90	0.91	0.91	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.01	4.73	0.50	0.87	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	42.19	8.52	1.09	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	43.73	7.09	2.36	0.59	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.36	7.47	1.11	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.98	6.70	2.46	1.79	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	35.89	7.46	0.60	0.40	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	39.53	4.75	1.02	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	52.41	9.49	1.60	1.77	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.10	12.38	2.60	1.77	1.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	48.67	9.05	2.22	0.85	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	38.51	6.64	1.33	0.44	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.76	7.90	1.33	0.83	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.12	7.35	1.23	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.77	5.98	0.83	1.03	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	38.74	6.46	1.04	0.69	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	39.36	5.00	1.67	0.83	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.37	6.83	1.54	0.88	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	41.57	5.53	0.98	0.49	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	37.12	7.46	1.62	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.69	7.70	5.45	0.32	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.67	4.55	1.33	0.76	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	34.80	6.80	2.37	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.44	6.08	3.34	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.64	6.69	0.63	0.94	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	31.40	5.49	1.10	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	36.19	5.89	1.12	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	32.96	6.30	1.39	0.65	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.03	5.88	2.14	0.53	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	37.18	5.51	1.68	0.61	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	28.89	5.96	1.30	0.26	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.97	5.96	1.08	0.54	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	45.35	9.03	1.47	1.11	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	43.20	7.02	1.54	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	71.41	2.98	1.98	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	41.95	7.52	2.11	1.19	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.20	6.25	3.63	0.61	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	95.06	15.50	6.10	1.78	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	50.36	6.77	1.99	0.60	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	41.60	5.39	0.46	0.46	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	38.87	5.11	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	37.24	7.20	1.56	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	27.41	5.93	0.28	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	34.13	6.46	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	4.95	2.47	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	38.68	6.58	1.55	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	43.32	4.81	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	1.74	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	28.64	4.23	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	26.36	4.94	1.24	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	3.33	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.36	6.99	1.40	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	36.61	6.86	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.10	8.39	0.84	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	38.80	5.73	0.64	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	30.91	5.43	0.34	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	4.18	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	29.21	8.02	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.08	5.92	1.78	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	8.47	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	36.45	5.80	2.07	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	38.20	6.90	0.92	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	10.54	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.22	5.38	0.77	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	34.55	6.19	1.30	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.77	6.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	36.22	5.01	0.77	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	54.09	11.30	1.03	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	57.15	12.42	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	45.77	8.02	1.89	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	5.43	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	42.73	10.17	1.53	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	41.08	7.18	0.40	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	37.99	6.91	1.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	2.36	0.00	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	35.01	8.75	1.75	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.89	8.34	3.07	2.19	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	4.24	0.85	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	8.36	1.79	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	30.57	4.85	0.00	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	62.77	11.41	2.28	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	60.29	9.15	2.08	2.49	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	80.96	14.62	3.37	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	29.18	5.39	0.63	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.48	6.68	0.00	0.42	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.62	2.32	1.16	2.20	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	31.40	2.19	0.84	1.35	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	29.58	2.28	0.91	1.82	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	37.49	2.84	0.55	1.42	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.31	2.79	0.86	1.50	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.71	1.72	0.65	1.51	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	31.63	1.12	0.62	1.62	1.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	28.31	2.06	0.86	0.86	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	29.79	1.28	0.64	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	46.45	6.72	0.00	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	80.07	9.52	3.46	0.87	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	2.64	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	69.13	9.88	3.88	1.06	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	73.38	7.99	1.45	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	34.44	4.90	1.05	1.75	0.52
Hepatocyte, donor1	11523-119I2	7.26	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	14.01	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	15.34	1.23	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	15.01	10.44	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	46.14	3.85	1.05	1.22	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	46.65	7.82	1.51	1.37	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	11.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	23.34	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	30.44	6.62	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	2.22	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.16	2.52	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	6.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.90	2.58	0.65	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	22.54	4.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	30.15	4.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.67	4.62	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	25.72	2.41	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	15.70	2.77	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.58	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	0.91	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	2.15	1.08	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	5.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	24.23	1.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	7.29	0.00	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	21.42	0.71	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.96	1.54	0.00	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	16.69	5.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	23.54	6.10	0.87	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	0.00	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	5.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	6.93	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	13.81	2.76	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	30.66	5.29	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	66.91	7.51	2.61	2.37	1.47
Keratinocyte - epidermal, donor2	11349-117G8	32.21	4.69	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	46.57	4.54	2.18	1.42	1.14
Keratinocyte - oral, donor1	11251-116E9	53.35	4.88	1.82	2.04	1.14
Keratocytes, donor1	11527-119I6	90.43	5.85	4.13	1.03	3.78
Keratocytes, donor2	11607-120I5	58.59	7.03	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	35.17	4.15	0.99	1.19	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	76.93	6.59	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	30.20	9.71	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	75.89	7.04	3.46	2.19	2.08
Lens Epithelial Cells, donor3	11690-122I7	63.77	9.18	2.02	1.31	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	55.02	6.88	2.37	1.07	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	36.56	3.07	1.40	2.23	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	39.20	3.94	2.52	1.57	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.72	3.76	0.00	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	37.82	4.73	1.26	1.58	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	35.26	4.53	1.08	0.75	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	29.96	5.34	0.00	1.64	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.88	5.06	1.01	1.26	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	36.17	4.64	0.70	1.27	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	34.02	4.35	1.19	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	36.26	5.04	1.36	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	39.62	3.89	1.48	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	37.28	4.53	1.05	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	43.65	4.77	2.62	2.15	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	39.42	4.81	0.82	0.82	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	40.03	4.00	1.85	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	35.54	5.61	0.94	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	45.38	6.77	2.38	2.20	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	38.18	5.59	1.65	1.97	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	39.54	7.32	0.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	41.57	7.47	1.74	0.75	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	37.34	4.85	2.42	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	41.20	4.85	1.35	2.15	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	40.87	8.02	1.51	1.06	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	2.07	0.52	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	39.57	3.56	0.84	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	38.50	6.62	0.90	0.75	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.83	6.19	0.00	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.76	3.01	0.94	1.69	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	41.88	3.71	1.70	1.06	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.50	4.36	0.00	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	39.36	5.29	0.00	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	41.38	6.32	2.11	1.49	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	44.80	4.81	0.74	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	31.38	4.45	0.74	1.24	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	42.49	4.95	2.20	0.96	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.78	3.86	1.29	1.61	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	37.74	4.87	0.61	1.52	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.61	4.34	1.12	1.40	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.11	6.40	1.78	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	41.69	5.33	0.48	3.88	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.08	6.54	1.71	2.33	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	36.17	5.01	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	55.86	6.53	0.98	0.98	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	38.37	5.89	0.94	1.18	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	62.25	8.66	3.22	1.73	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.98	2.05	2.31	2.31	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	38.79	5.07	0.90	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	3.84	1.53	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.07	2.23	0.00	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.96	4.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.73	3.52	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	3.74	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	14.43	2.06	0.52	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	2.38	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	24.43	3.17	0.45	0.00	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.12	3.78	0.29	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.11	2.70	0.00	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	29.26	4.47	0.54	1.63	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	28.24	1.54	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.47	1.76	0.71	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	2.00	0.67	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	2.04	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.08	2.13	0.00	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.78	3.40	0.19	0.19	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	33.13	6.14	0.61	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	4.89	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.12	2.50	0.42	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	16.82	1.12	0.00	0.56	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	2.06	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.16	3.48	0.87	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.74	4.19	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	22.13	2.77	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	28.99	3.89	0.35	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	21.76	1.48	0.00	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	2.30	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.41	3.84	0.38	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.38	2.83	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	6.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	25.31	3.62	0.45	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	2.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	38.09	2.24	0.00	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.81	4.09	1.11	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.65	3.88	0.00	0.43	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.98	1.71	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.99	3.33	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	29.56	6.03	0.00	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.88	7.11	1.42	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	29.22	2.06	0.34	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	28.45	2.15	1.07	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	29.63	2.02	0.00	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.15	3.33	0.37	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	3.49	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	5.29	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.41	2.80	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	3.63	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	2.30	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.12	2.96	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	2.82	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	19.61	0.50	0.00	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.04	0.90	0.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	3.44	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.95	3.56	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.12	2.35	1.17	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	22.43	1.32	0.66	0.00	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	25.43	2.08	1.04	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.13	6.13	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.72	1.12	0.00	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.97	2.65	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.76	4.24	0.39	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	3.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.07	1.44	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.83	4.77	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	25.52	0.61	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.91	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.84	2.28	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	2.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	34.47	2.42	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.45	4.12	0.00	0.95	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	26.12	3.73	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	23.56	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.03	4.11	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.71	4.24	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.24	3.97	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	33.70	4.58	0.83	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	31.32	3.92	0.78	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.47	4.59	0.42	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	30.20	4.18	0.93	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.74	3.35	0.00	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	33.68	3.74	0.00	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.29	5.66	0.81	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	3.67	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	33.79	6.22	0.00	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	42.74	3.99	1.14	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	27.61	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.32	3.28	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.54	4.01	0.89	0.89	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	32.75	6.50	0.52	0.78	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	29.18	1.99	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	12.76	3.65	0.46	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	13.95	3.12	0.18	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	21.24	3.93	0.66	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.33	2.66	1.06	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	53.56	6.81	2.38	2.54	0.79
Mallassez-derived cells, donor3	11930-125I4	53.09	3.89	1.25	1.11	1.53
Mammary Epithelial Cell, donor1	11273-116H4	35.37	2.59	1.30	1.00	1.10
Mammary Epithelial Cell, donor2	11350-117G9	34.46	2.61	0.58	0.87	1.16
Mammary Epithelial Cell, donor3	11422-118F9	42.40	3.49	2.74	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	13.56	6.10	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	18.82	6.16	0.76	0.00	0.22
Mast cell, donor2	11565-120D8	16.05	6.24	0.30	0.30	0.59
Mast cell, donor3	11566-120D9	22.74	3.60	0.00	0.23	0.90
Mast cell, donor4	11567-120E1	18.44	6.74	0.53	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	16.19	6.10	0.22	0.22	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	9.34	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	17.55	5.05	0.34	0.23	0.34
Mast cell, expanded, donor8	11941-126A6	27.62	7.36	0.84	0.33	1.00
Melanocyte - dark, donor1	11502-119F8	41.89	4.18	1.39	1.19	0.30
Melanocyte - dark, donor2	11582-120F7	24.23	3.81	0.00	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	52.30	7.39	1.88	0.80	0.58
Melanocyte - light, donor1	11274-116H5	52.42	3.06	2.82	0.94	1.65
Melanocyte - light, donor2	11351-117H1	54.60	6.14	1.36	1.36	0.68
Melanocyte - light, donor3	11423-118G1	40.76	0.87	0.87	1.73	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	44.36	6.77	1.77	0.31	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	34.96	3.23	0.27	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	55.45	4.82	2.68	1.87	0.54
Meningeal Cells, donor1	11493-119E8	80.89	16.38	0.37	0.37	0.12
Meningeal Cells, donor2	11573-120E7	55.02	10.12	1.32	1.32	0.00
Meningeal Cells, donor3	11654-122E7	45.23	11.25	0.73	0.49	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.35	5.13	1.14	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	63.30	7.65	2.11	1.41	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	43.37	10.51	2.63	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	37.94	5.23	0.00	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.86	3.59	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	46.80	5.51	1.48	1.69	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	47.75	6.53	0.50	2.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	50.32	14.06	2.20	0.88	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	64.29	5.11	3.65	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	70.38	10.64	1.84	2.05	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	37.95	9.28	0.69	1.39	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	62.45	13.75	2.60	1.12	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	49.74	4.87	2.37	1.58	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	52.23	7.12	1.48	2.08	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	56.05	2.34	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	49.95	9.61	3.20	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	33.67	6.38	0.00	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	47.22	4.07	0.94	1.56	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	32.66	3.63	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	49.32	7.42	1.86	2.39	0.53
Mesothelial Cells, donor2	12156-128G5	48.55	7.01	1.00	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	51.52	6.07	1.95	1.66	1.08
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.73	3.20	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.08	2.65	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.74	0.62	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.37	2.90	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.02	1.50	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.22	6.05	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.90	3.86	1.02	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.88	1.58	0.79	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.88	1.90	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	2.63	1.32	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	13.79	1.91	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.01	3.58	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	6.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.79	2.51	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.46	1.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	0.55	0.55	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.29	2.53	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	10.10	0.63	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.84	2.24	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.58	2.15	0.43	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.23	1.33	0.22	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.32	2.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.06	1.63	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.84	1.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.40	2.00	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.51	1.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.69	2.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.21	0.99	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.47	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.88	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.73	0.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	6.23	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	1.75	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	2.11	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.10	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.11	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.26	2.90	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.00	0.52	0.26	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	8.58	2.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.47	1.33	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.67	2.39	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.59	2.83	0.57	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6.37	2.55	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.95	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.34	1.14	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.81	2.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.31	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	1.96	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.82	3.53	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.72	4.32	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.19	2.89	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	5.66	0.00	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	7.53	0.00	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	24.97	0.99	0.66	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	2.10	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	21.75	2.97	0.59	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	5.59	0.93	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	18.03	5.63	0.00	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.78	1.07	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	12.44	2.04	0.68	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	26.02	4.76	1.10	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	3.11	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	22.22	2.02	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.01	0.42	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	58.81	9.91	3.02	0.65	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.67	7.84	1.05	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	58.74	10.01	2.00	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	67.20	5.43	0.83	2.50	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	32.70	1.14	0.76	0.19	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	73.41	12.77	3.19	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	7.48	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	37.67	4.19	0.42	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	65.78	6.74	1.16	1.39	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	63.50	7.57	1.62	2.16	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	51.30	7.57	0.42	1.47	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.67	7.94	0.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	26.80	2.17	0.81	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	42.62	4.99	0.23	1.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	44.25	6.21	1.63	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	45.93	8.02	1.28	1.64	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	47.21	5.30	1.06	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	42.02	6.00	0.60	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.16	0.66	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.97	4.55	2.76	0.81	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	58.91	8.64	1.76	1.76	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	33.05	4.22	2.11	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	41.83	6.44	0.92	0.46	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	49.17	7.39	1.93	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.52	1.38	1.03	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	58.15	7.80	2.01	1.78	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	46.57	4.23	0.42	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	34.65	3.32	0.47	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	61.38	8.16	4.29	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	65.64	10.00	3.00	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	54.10	8.12	1.35	1.35	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	32.93	3.97	1.59	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	53.86	4.64	5.57	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	41.62	3.41	0.38	0.76	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	66.15	8.47	1.63	2.93	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	56.22	6.54	3.92	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	53.37	7.69	0.90	1.81	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	45.86	5.29	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	42.55	1.99	1.33	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	59.53	7.94	1.49	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	80.01	8.04	3.83	2.30	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	42.64	4.23	1.51	0.60	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	42.88	9.95	2.43	2.21	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	42.69	2.03	2.71	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	53.04	5.49	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	69.87	4.72	2.83	0.94	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	54.48	3.03	3.63	1.21	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	48.26	5.54	1.58	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	13.60	1.13	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	37.89	4.97	0.75	1.24	1.24
Myoblast, donor2	11322-117D8	43.34	5.56	1.15	1.92	0.77
Myoblast, donor3	11398-118D3	41.37	5.21	1.68	1.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	25.54	2.77	0.73	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	33.52	6.46	0.62	0.31	1.23
Natural Killer Cells, donor2	11311-117C6	32.27	5.13	0.60	0.30	1.21
Natural Killer Cells, donor3	11387-118C1	36.63	4.42	0.55	0.55	1.84
Neural stem cells, donor1	11275-116H6	55.17	19.60	0.36	2.54	2.54
Neural stem cells, donor2	11352-117H2	51.99	13.48	1.93	1.93	1.93
Neurons, donor1	11494-119E9	25.03	4.55	1.14	0.00	0.00
Neurons, donor2	11574-120E8	37.21	9.47	0.88	0.22	1.10
Neurons, donor3	11655-122E8	30.42	4.11	0.82	2.47	1.64
Neutrophils, donor1	11233-116C9	71.46	1.86	0.93	0.93	5.57
Neutrophils, donor2	11314-117C9	69.57	2.90	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	94.07	5.50	4.89	3.05	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	37.64	7.36	1.07	0.71	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	41.35	7.16	0.98	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	37.90	4.81	1.20	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	47.63	7.85	1.79	1.10	1.10
Olfactory epithelial cells, donor2	11934-125I8	59.49	6.51	2.17	3.33	1.59
Olfactory epithelial cells, donor3	11935-125I9	64.13	8.40	1.93	1.70	0.91
Olfactory epithelial cells, donor4	11936-126A1	82.20	10.71	1.85	2.14	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	74.63	6.02	3.61	4.21	2.41
Osteoblast - differentiated, donor1	11276-116H7	43.18	5.10	1.28	1.28	0.21
Osteoblast - differentiated, donor2	11353-117H3	28.58	3.43	1.14	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	35.38	3.10	1.24	2.48	0.00
Osteoblast, donor1	11277-116H8	60.00	7.43	1.56	0.78	1.76
Osteoblast, donor2	11354-117H4	56.89	10.53	1.40	3.51	0.70
Osteoblast, donor3	11426-118G4	60.07	6.93	2.84	3.20	0.53
Pancreatic stromal cells, donor1	11249-116E7	39.42	4.63	1.60	0.76	0.59
Pericytes, donor1	11491-119E6	69.43	14.02	1.11	0.89	0.22
Pericytes, donor2	11571-120E5	54.10	13.36	0.68	0.45	0.23
Pericytes, donor3	11652-122E5	79.35	11.39	2.24	2.24	0.81
Perineurial Cells, donor1	11499-119F5	58.09	8.59	2.26	0.79	0.57
Perineurial Cells, donor2	11579-120F4	40.67	4.51	1.38	0.28	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	18.49	6.06	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	18.12	3.43	0.00	0.49	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	21.09	3.36	0.39	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	46.16	5.74	1.67	0.96	1.67
Placental Epithelial Cells, donor2	11355-117H5	53.23	6.65	1.11	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	47.51	8.83	1.37	1.77	2.36
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	38.61	5.06	1.58	1.90	1.58
Preadipocyte - breast, donor1	11467-119B9	32.08	10.69	1.31	1.69	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.67	4.57	0.65	0.26	1.17
Preadipocyte - breast, donor2	11328-117E5	43.45	7.66	2.25	1.35	1.35
Preadipocyte - omental, donor1	11468-119C1	42.84	4.90	1.28	1.81	1.49
Preadipocyte - omental, donor2	11329-117E6	55.00	9.60	2.18	1.75	0.00
Preadipocyte - omental, donor3	11403-118D8	67.47	10.17	2.72	1.00	1.00
Preadipocyte - perirenal, donor1	11469-119C2	54.13	6.89	0.00	3.94	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	72.17	9.21	3.69	3.38	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	54.54	8.85	1.24	0.71	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	49.38	5.11	0.68	1.53	0.51
Preadipocyte - visceral, donor1	11280-116I2	55.42	9.22	1.02	1.21	0.37
Preadipocyte - visceral, donor2	11357-117H7	57.98	7.36	2.30	0.92	1.38
Preadipocyte - visceral, donor3	11429-118G7	46.29	5.75	0.63	0.94	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	42.99	5.58	0.91	1.81	1.66
Prostate Epithelial Cells, donor2	11331-117E8	63.37	6.50	1.76	2.98	1.35
Prostate Epithelial Cells, donor3	11404-118D9	37.78	2.39	1.71	2.76	1.65
Prostate Stromal Cells, donor1	11254-116F3	34.97	4.21	0.80	0.91	0.80
Prostate Stromal Cells, donor2	11332-117E9	51.46	8.79	2.15	1.43	0.90
Prostate Stromal Cells, donor3	11405-118E1	37.44	4.69	1.88	1.46	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	60.95	10.95	1.46	1.09	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	41.03	4.71	1.25	0.76	1.18
Renal Epithelial Cells, donor1	11517-119H5	104.49	19.27	2.03	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	53.35	12.09	3.56	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	51.03	9.42	1.91	1.91	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	68.77	6.81	1.36	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	66.30	9.03	1.48	1.08	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	47.95	8.44	1.11	0.89	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	85.18	11.31	2.00	2.66	2.00
Renal Mesangial Cells, donor1	11518-119H6	70.43	14.53	2.42	1.10	0.88
Renal Mesangial Cells, donor2	11598-120H5	73.36	8.78	0.00	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	78.51	11.93	2.77	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	57.17	10.47	0.54	1.61	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	40.06	8.43	1.69	0.84	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	62.10	9.26	1.54	1.93	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	66.89	2.07	2.07	1.30	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	75.89	10.23	3.13	1.71	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	73.07	4.12	2.06	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.36	6.27	0.75	0.25	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	41.83	3.34	1.20	1.20	2.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	1.79	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	9.36	1.10	0.00	0.00	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.18	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.96	3.64	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.63	3.77	0.20	0.50	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	22.42	6.47	0.22	0.78	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.85	3.35	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	29.49	4.20	0.47	0.35	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	30.05	4.62	0.46	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	20.81	4.11	0.27	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	28.29	4.84	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	27.60	4.12	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.10	4.16	0.29	0.57	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	27.69	4.83	0.43	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.66	5.75	0.44	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	20.07	5.16	0.57	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	29.16	3.07	0.09	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	22.55	5.26	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.86	4.91	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	29.59	2.92	0.39	0.29	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	27.50	4.58	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.70	4.70	0.11	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	29.71	4.48	0.56	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.34	5.13	0.34	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	25.34	4.01	0.00	0.18	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.33	5.64	0.25	1.10	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.70	4.16	0.81	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.29	4.48	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.98	3.77	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	31.10	6.55	0.47	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	24.88	5.18	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.00	4.42	0.44	1.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	30.91	3.97	0.00	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	25.71	5.52	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	30.65	5.45	0.51	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	33.16	7.90	0.77	0.39	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	27.17	5.33	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	32.37	6.86	0.55	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	31.36	5.09	0.66	0.66	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	24.88	3.92	0.34	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.67	3.99	0.15	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.66	5.33	1.07	1.60	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	24.61	3.59	0.28	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	33.81	6.19	0.24	1.19	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	40.51	5.64	1.41	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.59	5.37	0.57	0.19	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	28.30	5.59	0.70	1.05	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.55	7.25	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	27.66	3.92	0.37	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	39.15	5.82	1.16	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.34	3.04	0.61	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	22.30	2.41	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.13	4.98	0.68	0.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	33.85	4.79	0.60	0.30	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	25.74	3.31	0.24	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	31.80	4.70	0.21	0.85	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	26.44	2.40	0.60	1.20	1.20
Schwann Cells, donor1	11498-119F4	65.64	9.03	1.50	1.50	0.19
Schwann Cells, donor2	11578-120F3	17.01	10.21	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	42.50	9.20	0.88	1.10	0.44
Sebocyte, donor1	11220-116B5	106.27	10.41	4.93	5.48	2.74
Sebocyte, donor2	11301-117B5	71.23	4.14	2.76	3.68	0.92
Sebocyte, donor3	11378-118B1	58.12	5.98	2.06	1.44	1.44
Sertoli Cells, donor1	11255-116F4	56.32	6.63	4.97	1.66	1.66
Sertoli Cells, donor2	11333-117F1	50.84	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	44.08	5.98	1.32	0.53	0.53
Skeletal Muscle Cells, donor2	11358-117H8	31.08	3.61	1.45	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	74.41	10.87	3.34	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	34.72	5.34	0.16	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	30.47	5.20	0.30	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	40.17	5.69	0.77	0.77	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	29.49	4.79	0.88	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	36.96	4.85	1.00	0.86	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	41.57	5.06	1.19	1.09	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.51	7.08	1.43	1.01	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	45.60	3.62	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	35.50	9.77	0.69	0.83	0.41
Skin - palm, donor1	10286-104F7	37.61	10.74	2.69	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	43.10	4.76	1.44	1.59	1.01
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	53.98	7.36	0.00	1.64	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	41.80	2.47	0.65	2.08	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	36.28	2.92	1.67	1.67	2.22
Small Airway Epithelial Cells, donor2	11334-117F2	55.42	3.80	2.11	3.24	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	78.23	8.46	3.59	2.33	3.17
Small Airway Epithelial Cells, donor3	11406-118E2	53.14	3.90	3.97	3.37	2.10
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	46.90	6.17	1.23	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	50.69	13.12	0.44	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	94.05	9.41	2.35	3.53	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	75.14	9.72	2.43	1.99	1.99
Smooth Muscle Cells - Aortic, donor2	11360-117I1	80.33	8.66	1.97	2.36	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	93.48	12.36	5.41	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	5.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	81.31	9.85	3.86	3.59	2.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	56.52	9.53	1.11	2.22	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.92	2.82	0.38	1.02	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.68	8.47	1.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	52.86	8.86	1.18	2.36	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	53.24	5.41	2.28	1.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	66.37	11.06	2.11	1.95	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.96	6.39	1.22	0.30	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	70.72	10.61	3.28	2.53	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	6.12	12.24	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	90.12	11.92	1.91	4.29	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	30.97	5.75	1.18	0.15	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	36.59	6.03	0.86	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	40.51	6.09	1.15	0.63	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	90.80	11.76	3.56	4.64	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	68.98	7.55	3.23	4.31	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	57.68	6.57	0.90	1.20	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	61.79	12.63	1.71	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	28.35	5.26	0.79	0.71	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	63.61	10.97	1.71	1.71	1.71
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	100.12	9.56	3.64	5.01	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	81.51	8.45	2.42	1.81	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	53.25	3.18	0.79	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	49.00	6.13	0.93	0.27	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	43.70	5.13	0.75	0.50	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.17	2.79	2.03	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	74.63	10.55	2.71	2.56	1.96
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	56.26	7.50	3.00	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	87.87	5.17	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	97.20	16.74	4.65	3.26	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	94.92	12.62	4.54	4.04	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	87.44	7.52	2.19	3.76	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	40.12	9.44	1.18	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	48.73	9.58	1.83	0.92	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	35.97	3.27	1.87	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	68.22	6.91	2.30	2.59	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	68.84	6.63	2.80	3.06	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	59.42	5.64	1.88	1.69	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.22	3.77	0.28	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	46.75	6.37	1.59	1.51	1.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	69.05	9.52	0.48	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	59.94	5.14	4.16	2.69	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	47.72	7.95	0.22	1.10	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.86	5.56	1.17	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.60	4.47	0.97	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	32.53	4.76	1.32	0.79	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.55	0.37	0.37	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	37.73	7.19	0.72	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	29.81	5.11	0.57	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	36.24	1.97	0.39	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	19.05	2.29	0.00	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	21.16	4.79	0.40	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	3.34	0.42	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	19.71	3.67	0.92	0.92	0.00
Synoviocyte, donor1	11291-117A4	54.54	6.06	1.35	2.36	1.51
Synoviocyte, donor2	11368-117I9	48.78	3.52	2.35	2.01	0.67
Synoviocyte, donor3	11440-118H9	37.09	6.03	1.34	0.45	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	82.19	10.36	0.71	1.79	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	5.95	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	62.05	8.10	2.78	1.39	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	31.68	3.08	0.93	1.36	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	47.16	3.48	1.16	1.93	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	56.69	4.58	1.15	3.44	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	44.41	2.95	2.21	1.48	2.58
Urethra, donor2	10319-105A4	35.97	7.19	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	73.85	9.56	2.66	1.33	1.06
Urothelial Cells, donor2	11600-120H7	54.08	4.01	4.01	2.40	1.60
Urothelial Cells, donor3	11681-122H7	59.36	6.42	2.75	1.15	1.15
Urothelial cells, donor0	11216-116B1	92.28	7.36	2.67	3.57	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	41.82	1.78	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	8.58	1.43	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	25.33	1.37	2.74	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.20	3.10	0.69	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	32.54	4.07	1.74	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	45.81	5.21	0.00	1.04	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	4.59	0.92	0.92	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	32.86	2.74	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	55.76	9.01	1.60	0.49	0.99
Wilms' tumor cell line:HFWT	10597-108E3	38.72	7.04	3.52	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	46.37	6.42	0.84	1.40	1.12
achilles tendon, donor2	10292-104G4	22.73	8.27	2.07	4.13	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	14.79	1.78	0.51	0.00	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	10.45	5.34	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	16.38	5.10	0.24	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	33.20	7.07	0.82	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.33	4.50	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	19.46	3.17	0.21	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	29.67	3.81	0.27	0.27	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.03	5.29	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	22.05	6.53	0.41	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.91	2.72	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	15.64	3.86	0.18	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	11.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.66	3.25	0.00	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.57	4.14	0.26	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	12.57	3.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.01	1.86	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.45	1.23	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	25.48	1.53	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.90	5.55	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	26.08	4.25	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	26.00	4.57	0.00	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.13	1.78	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	34.36	7.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	32.77	4.14	0.38	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	49.72	11.34	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	39.36	5.62	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	48.04	3.53	2.35	1.18	0.94
adipose tissue, adult, pool1	10010-101C1	43.90	4.03	1.71	1.71	2.33
adipose, donor1	10184-103D4	38.70	2.35	0.00	0.59	0.00
adipose, donor2	10185-103D5	60.83	12.17	1.62	1.22	2.03
adipose, donor3	10186-103D6	46.02	10.07	0.27	1.36	1.63
adipose, donor4	10187-103D7	28.60	2.60	0.00	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	34.88	7.89	0.95	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	32.74	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	24.41	2.40	0.40	0.13	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.80	4.29	0.00	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	38.49	3.94	1.85	1.16	1.62
amniotic membrane cells, donor2	12236-129G4	41.92	5.41	2.37	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	33.58	3.54	0.59	0.59	0.59
amygdala - adult, donor10196	10167-103B5	61.66	16.60	0.00	1.19	2.37
amygdala, adult, donor10252	10151-102I7	87.80	12.57	4.26	3.45	3.45
amygdala, newborn, donor10223	10360-105E9	27.76	9.36	1.61	0.00	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	86.46	13.88	1.53	1.91	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	31.99	4.41	0.44	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	46.43	9.35	1.00	0.00	1.00
aorta, adult, pool1	10052-101G7	59.62	4.31	2.55	1.57	0.98
appendix, adult	10189-103D9	31.05	3.49	0.78	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	32.33	1.03	0.69	0.69	1.03
artery, adult	10190-103E1	40.76	1.36	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	54.47	5.50	1.74	0.14	0.43
b cell line:RPMI1788	10427-106D4	15.76	3.87	1.04	1.04	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	56.04	5.55	2.77	2.77	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	69.46	4.07	1.79	1.59	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	19.25	1.34	0.17	0.00	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.07	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	26.07	3.37	0.54	0.65	0.87
blood, adult, pool1	10053-101G8	22.15	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	64.23	6.85	0.86	2.57	0.00
bone marrow, adult	10192-103E3	32.39	4.05	0.67	0.67	0.67
brain, adult, donor1	10084-102B3	109.68	11.28	5.13	8.20	3.08
brain, adult, pool1	10012-101C3	73.83	9.02	2.12	4.12	4.68
brain, fetal, pool1	10085-102B4	72.13	18.70	13.36	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	51.21	4.29	1.32	0.33	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	66.16	6.37	2.37	1.37	4.49
breast, adult, donor1	10080-102A8	74.50	3.79	1.89	2.53	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	74.19	8.13	4.07	0.89	1.65
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.05	4.33	1.24	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	10.59	2.07	0.23	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	41.15	1.21	0.73	2.42	3.87
carcinoid cell line:NCI-H1770	10703-109H1	20.22	0.94	0.47	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	43.86	3.50	1.97	1.42	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	24.08	3.80	0.00	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.62	6.65	0.27	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	51.81	4.61	0.00	3.45	3.45
caudate nucleus, adult, donor10252	10164-103B2	49.19	8.53	4.02	3.51	2.51
caudate nucleus, adult, donor10258	10379-105H1	52.73	12.99	1.53	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	26.37	6.59	0.00	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	99.05	5.83	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	92.66	6.62	7.05	4.91	4.70
cerebellum, adult, pool1	10083-102B2	61.40	10.69	3.10	4.48	1.38
cerebellum, newborn, donor10223	10357-105E6	47.33	7.47	0.00	3.32	0.83
cerebral meninges, adult	10188-103D8	50.93	7.82	0.25	2.02	3.53
cerebrospinal fluid, donor2	10294-104G6	21.20	2.19	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	23.29	2.59	1.15	0.29	1.58
cervical cancer cell line:ME-180	10553-107I4	44.41	3.31	1.16	1.66	1.82
cervix, adult, pool1	10013-101C4	40.95	5.98	1.47	1.26	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	38.88	4.04	1.39	1.53	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	2.61	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	42.75	4.23	0.62	1.37	0.50
choriocarcinoma cell line:SCH	10785-110H2	38.20	4.44	0.49	1.48	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	44.12	4.27	0.95	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	26.21	4.56	0.00	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	67.22	7.66	2.39	1.89	1.49
chorionic membrane cells, donor3	12240-129G8	23.08	3.85	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	3.03	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.74	5.57	0.38	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	33.16	4.01	0.63	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.24	3.08	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	9.68	2.66	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.99	2.24	0.00	0.41	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	12.66	3.24	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	29.19	4.95	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	37.03	14.63	0.00	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	59.34	3.82	2.08	1.74	1.21
colon carcinoma cell line:CACO-2	10513-107D9	46.31	5.13	0.55	1.28	0.73
colon carcinoma cell line:COLO-320	10420-106C6	31.17	3.04	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	45.22	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	27.03	2.00	1.06	0.94	0.59
colon, fetal, donor1	10070-101I7	19.78	2.47	1.24	1.85	1.24
common myeloid progenitor CMP, donor1	12130-128D6	64.17	22.92	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	27.20	2.97	0.42	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.53	3.92	0.45	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	25.81	4.37	0.42	0.28	0.28
corpus callosum, adult, pool1	10042-101F6	141.96	9.84	4.64	8.18	12.94
cruciate ligament, donor2	10295-104G7	32.42	4.05	0.81	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	47.35	4.01	4.82	0.80	2.41
diencephalon, adult	10193-103E4	55.44	9.84	2.40	1.20	4.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	6.89	2.76	0.23	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	56.42	4.36	0.77	2.05	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	29.61	0.48	1.69	0.00	0.24
ductus deferens, adult	10196-103E7	46.84	3.99	0.50	1.50	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	60.49	5.76	4.32	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	4.41	0.74	0.00	2.21
dura mater, adult, donor1	10041-101F5	43.11	8.67	0.58	1.16	1.49
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	23.10	3.33	0.89	0.67	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	40.55	7.88	0.57	0.29	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	80.16	12.33	1.85	1.85	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	66.90	6.36	1.21	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	79.35	9.26	0.93	1.85	0.62
embryonic pancreas cell line:2C6	10603-108E9	78.81	5.25	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	62.35	6.03	1.01	0.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.57	7.79	1.45	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	45.99	5.63	1.45	0.64	0.48
epidermoid carcinoma cell line:A431	10426-106D3	71.36	6.00	2.22	2.56	1.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	40.36	3.52	0.77	1.32	0.44
epididymis, adult	10197-103E8	33.70	6.91	0.84	0.42	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	27.32	4.61	0.18	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.09	3.93	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	27.00	1.44	0.39	1.18	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	28.84	1.87	0.49	1.18	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.03	2.91	0.34	0.56	0.67
esophagus, adult, pool1	10015-101C6	25.91	1.70	1.27	0.64	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.54	25.17	1.00	1.13	0.50
eye - muscle inferior rectus, donor1	10272-104E2	36.22	7.24	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	16.83	2.10	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	46.13	2.98	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	33.25	4.59	0.00	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	11.66	8.74	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	55.93	5.08	2.03	2.03	4.07
fibrosarcoma cell line:HT-1080	10758-110E2	39.36	4.49	1.41	0.51	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.17	4.99	1.19	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	100.11	17.64	3.19	4.60	5.91
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	48.34	3.60	3.00	1.50	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	55.04	8.14	1.28	0.91	0.64
gall bladder, adult	10198-103E9	52.63	3.62	1.45	0.72	1.69
gamma delta positive T cells, donor1	11937-126A2	35.43	7.52	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	36.98	5.98	0.75	0.37	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	34.01	1.90	0.84	1.27	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.66	2.32	1.74	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	44.27	7.05	0.66	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	30.20	7.32	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.78	3.88	1.83	1.60	0.91
giant cell carcinoma cell line:LU65	10487-107B1	25.82	1.84	1.72	1.95	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	35.41	5.60	0.14	0.56	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	56.87	2.49	0.25	1.75	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	41.06	6.02	0.74	1.16	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	44.52	5.48	1.12	1.40	1.54
glioblastoma cell line:T98G	10485-107A8	49.67	5.85	1.66	1.10	0.55
glioma cell line:GI-1	10413-106B8	38.07	3.81	2.64	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	91.84	12.39	0.00	2.92	7.29
globus pallidus, adult, donor10252	10161-103A8	108.38	8.06	4.64	6.35	6.35
globus pallidus, adult, donor10258	10367-105F7	54.77	1.37	1.37	0.00	4.11
globus pallidus, newborn, donor10223	10364-105F4	37.84	8.53	0.53	0.53	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	66.07	12.24	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	55.68	3.84	2.88	0.96	0.64
hIPS +CCl2, biol_rep1	14383-156B9	31.68	6.89	0.46	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	32.47	5.94	0.00	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	37.36	8.37	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	8.62	4.31	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	30.18	6.86	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	45.24	9.93	1.10	1.10	2.21
hairy cell leukemia cell line:Mo	10712-109I1	95.97	8.33	2.01	3.16	0.57
heart - mitral valve, adult	10205-103F7	47.54	3.59	1.49	0.90	1.79
heart - pulmonic valve, adult	10206-103F8	47.33	3.92	1.83	1.83	2.35
heart - tricuspid valve, adult	10207-103F9	73.27	4.16	2.50	2.50	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	37.34	4.08	0.61	1.22	1.02
heart, adult, diseased, donor1	10051-101G6	52.80	5.11	2.13	2.13	2.13
heart, adult, pool1	10016-101C7	43.24	3.45	0.69	0.92	0.46
heart, fetal, pool1	10046-101G1	66.74	7.70	1.95	2.36	2.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	101.81	7.71	5.86	3.70	2.16
hepatoblastoma cell line:HuH-6	10633-108I3	41.62	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	40.44	5.75	0.77	0.77	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	40.42	3.76	0.61	0.49	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	41.43	6.06	0.91	0.61	0.71
hepatoma cell line:Li-7	10484-107A7	26.14	1.22	0.78	0.67	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.96	2.61	0.50	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	50.16	17.03	0.95	0.95	1.89
hippocampus, adult, donor10252	10153-102I9	90.01	7.76	4.69	8.98	3.67
hippocampus, adult, donor10258	10374-105G5	53.78	18.92	1.49	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	34.54	8.46	0.00	1.41	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	21.97	4.27	0.00	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	35.15	5.89	0.98	0.59	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	28.69	4.32	0.25	0.51	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	57.51	9.59	0.00	0.00	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	61.45	9.81	1.29	1.03	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	44.79	8.73	0.38	0.76	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.38	5.84	0.58	0.58	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	64.84	10.77	1.72	1.51	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.62	7.92	0.42	1.25	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	28.65	8.76	0.71	0.24	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	42.43	5.95	1.13	0.64	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	32.99	5.39	0.67	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.11	4.69	0.63	0.78	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	28.99	4.91	1.47	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	0.87	0.00	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	84.19	8.02	1.34	0.95	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	70.21	12.21	0.87	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.98	6.50	0.00	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	52.00	11.49	0.38	0.38	3.58
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	51.38	7.73	0.91	0.91	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	42.29	7.52	0.31	1.25	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.13	6.37	0.65	0.98	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.32	6.68	1.16	1.45	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	32.28	8.97	0.00	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.06	5.73	1.48	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	47.93	5.42	1.43	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	32.26	4.08	0.82	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	54.22	6.34	0.70	1.41	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	56.70	8.24	2.22	0.63	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	52.05	11.20	0.30	1.82	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	44.99	10.34	1.55	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	42.51	5.31	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	24.88	5.90	0.77	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	33.75	6.90	1.53	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	39.38	9.84	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.17	7.39	0.34	0.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	40.09	7.25	0.72	0.48	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	30.30	6.68	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	31.71	5.37	0.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	70.90	7.95	0.92	1.53	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	41.37	5.30	0.33	0.00	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	62.94	12.59	0.55	0.55	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.13	9.77	0.00	0.72	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	44.48	10.32	0.36	0.36	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	35.80	3.58	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	46.86	9.34	1.08	0.41	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.98	8.35	0.54	0.81	0.54
immature langerhans cells, donor1	11904-125F5	25.67	2.18	0.24	0.73	0.00
immature langerhans cells, donor2	11905-125F6	16.63	1.58	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	109.02	19.21	4.73	4.45	4.92
keratoacanthoma cell line:HKA-1	10791-110H8	26.99	0.33	3.25	4.55	3.58
kidney, adult, pool1	10017-101C8	39.85	4.81	0.50	0.80	0.60
kidney, fetal, pool1	10045-101F9	52.70	9.69	0.92	0.85	1.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	48.15	8.38	0.99	1.14	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.36	0.69	0.28	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	54.87	1.83	1.47	2.94	0.92
left atrium, adult, donor1	10079-102A7	34.33	2.18	1.09	1.09	0.54
left ventricle, adult, donor1	10078-102A6	26.29	0.00	0.00	3.03	1.01
leiomyoblastoma cell line:G-402	10721-110A1	43.78	8.76	1.37	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	28.02	5.39	1.08	1.44	0.36
leiomyoma cell line:15242A	10570-108B3	29.35	9.24	0.00	1.63	0.54
leiomyoma cell line:15425	10571-108B4	37.88	5.34	0.97	1.21	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	53.32	6.27	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	32.11	3.90	1.06	0.47	0.47
liposarcoma cell line:KMLS-1	10782-110G8	38.12	3.75	1.41	1.41	0.78
liposarcoma cell line:SW 872	10726-110A6	53.97	3.78	2.31	1.34	0.85
liver, adult, pool1	10018-101C9	21.88	1.78	0.16	0.97	0.16
liver, fetal, pool1	10086-102B5	14.11	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	93.04	9.48	3.35	4.52	6.27
locus coeruleus, adult, donor10252	10165-103B3	69.58	7.38	4.06	4.80	5.17
locus coeruleus, adult, donor10258	10375-105G6	71.66	11.00	2.26	3.10	6.21
locus coeruleus, newborn, donor10223	10362-105F2	20.61	3.36	0.00	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	30.72	0.83	0.42	1.11	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	232.33	13.10	4.14	8.27	7.58
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	63.80	5.14	0.66	0.92	0.53
lung, adult, pool1	10019-101D1	55.52	2.84	2.13	1.42	1.30
lung, fetal, donor1	10068-101I5	62.22	11.13	1.14	1.14	2.28
lung, right lower lobe, adult, donor1	10075-102A3	57.28	2.75	1.37	1.83	2.29
lymph node, adult, donor1	10077-102A5	20.35	2.84	0.47	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	39.45	3.07	1.75	1.10	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	44.83	5.58	2.26	0.60	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	98.54	5.10	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	52.39	2.66	0.89	0.44	0.44
mature adipocyte, donor2	12232-129F9	67.24	2.49	2.28	1.25	2.28
mature adipocyte, donor3	12233-129G1	48.36	2.37	0.71	1.66	2.13
mature adipocyte, donor4	12234-129G2	38.17	3.16	0.26	1.32	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	62.19	5.48	3.34	1.43	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	73.32	9.02	0.00	2.26	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	98.39	8.83	6.25	5.52	4.23
medial frontal gyrus, adult, donor10258	10368-105F8	62.58	15.88	0.95	1.59	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	23.03	2.56	0.00	0.43	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	77.29	13.84	2.36	2.87	3.54
medial temporal gyrus, adult, donor10252	10156-103A3	100.59	10.19	4.67	7.43	4.88
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	40.45	13.48	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	39.48	8.97	0.72	1.08	2.15
medulla oblongata - adult, donor10196	10174-103C3	71.39	8.44	1.30	3.89	2.60
medulla oblongata, adult, donor10252	10155-103A2	72.45	4.80	3.10	4.64	3.87
medulla oblongata, adult, pool1	10038-101F2	110.12	9.71	3.84	8.16	7.92
medulla oblongata, newborn, donor10223	10361-105F1	42.36	3.47	1.74	1.39	2.43
medulloblastoma cell line:D283 Med	10838-111E1	25.68	5.31	0.66	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	60.16	6.24	1.83	1.35	0.37
melanoma cell line:COLO 679	10514-107E1	27.89	3.88	0.57	0.29	0.29
melanoma cell line:G-361	10465-106H6	31.49	4.34	1.36	0.81	0.81
meningioma cell line:HKBMM	10691-109F7	38.17	2.89	0.54	1.63	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	95.16	6.17	1.76	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	116.65	10.37	2.85	3.89	2.85
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.65	6.75	0.46	0.61	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.90	2.18	0.18	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	25.26	2.07	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	36.94	3.65	0.98	0.84	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	31.77	3.47	1.73	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	35.40	6.25	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	52.86	3.26	1.03	2.75	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	39.57	2.42	1.73	1.04	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	52.26	4.91	0.40	1.72	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	63.33	5.40	1.35	2.84	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	71.27	6.97	1.42	1.56	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	50.39	6.59	1.32	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	59.36	5.53	1.38	1.25	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	62.49	9.77	1.05	2.44	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.20	2.25	0.61	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	44.93	7.19	0.36	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	41.90	5.17	1.14	1.14	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	44.69	5.93	1.14	1.14	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	21.40	3.78	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.91	6.43	0.90	0.75	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	59.52	5.25	1.58	1.31	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	54.86	8.47	3.68	0.37	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	55.23	8.58	0.57	1.72	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.94	5.89	0.42	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.05	4.57	1.37	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.88	4.86	1.53	0.77	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.34	4.45	1.31	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	29.58	5.24	0.92	0.92	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	29.65	4.94	0.47	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	28.43	5.75	1.69	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	26.33	6.29	0.39	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.46	5.10	1.39	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.32	6.63	0.58	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	31.90	5.58	1.78	0.45	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.05	7.45	0.96	0.96	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	34.47	8.07	0.73	2.20	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.51	5.37	0.34	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.88	6.55	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	25.77	5.15	1.72	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	10.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.76	4.87	0.97	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	4.36	0.00	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	26.65	4.80	0.00	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.17	2.45	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.77	7.39	1.55	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	6.30	0.00	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	20.75	4.15	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	6.09	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	28.50	4.43	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.69	4.83	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.56	3.26	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	2.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	1.18	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.77	2.18	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	2.67	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	5.14	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.09	2.75	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	42.06	3.46	1.48	2.47	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	5.61	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.17	2.54	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	45.54	6.45	1.21	2.42	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	4.36	2.18	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	53.22	6.34	0.00	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.99	2.43	2.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	76.82	4.52	0.00	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	41.18	1.65	4.12	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.00	3.17	1.19	0.99	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.80	2.92	0.00	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	1.02	3.06	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	71.18	7.74	1.55	4.64	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	71.11	8.50	2.36	2.36	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	55.83	8.80	0.70	0.93	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.00	1.75	0.72	0.62	0.41
mesothelioma cell line:Mero-25	10850-111F4	58.10	5.22	0.91	1.36	0.91
mesothelioma cell line:Mero-41	10851-111F5	34.72	3.42	0.24	0.73	1.71
mesothelioma cell line:Mero-48a	10852-111F6	27.90	3.32	0.89	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	44.94	3.94	1.05	1.84	1.05
mesothelioma cell line:Mero-83	10854-111F8	37.79	6.13	0.17	1.02	1.19
mesothelioma cell line:Mero-84	10855-111F9	25.53	4.04	0.76	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	21.33	4.55	0.41	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	46.88	5.96	0.99	0.99	0.99
mesothelioma cell line:NCI-H226	10846-111E9	22.08	2.90	0.54	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	39.29	3.25	0.68	1.02	0.51
mesothelioma cell line:NCI-H28	10845-111E8	14.25	2.54	0.25	0.00	0.25
mesothelioma cell line:No36	10857-111G2	28.05	3.91	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	48.50	3.52	1.08	1.90	1.90
migratory langerhans cells, donor1	11901-125F2	20.34	2.69	0.77	0.38	0.58
migratory langerhans cells, donor2	11902-125F3	23.57	3.54	0.24	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	33.20	2.33	0.54	0.36	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.89	3.26	1.31	1.63	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	36.03	4.24	3.18	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	104.12	3.92	6.45	4.61	2.30
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.89	2.28	0.19	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	26.98	4.80	0.37	0.55	0.74
myeloma cell line:PCM6	10474-106I6	35.18	2.17	1.78	1.98	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	36.52	4.06	1.01	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	32.95	3.14	1.77	0.98	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	28.52	2.56	1.56	0.45	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	21.40	1.10	0.74	0.51	0.74
nasal epithelial cells, donor2	12227-129F4	38.09	3.86	2.21	0.55	1.66
neuroblastoma cell line:CHP-134	10508-107D4	26.92	7.59	0.69	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	26.57	7.48	1.12	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	31.63	2.95	1.05	1.05	0.42
neuroblastoma cell line:NH-12	10555-107I6	24.41	5.22	0.00	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.00	5.22	0.71	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	20.75	4.28	0.00	0.16	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	19.92	4.23	0.40	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	40.05	6.36	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	65.21	6.92	2.40	2.13	2.13
neutrophil PMN, donor1	12133-128D9	44.62	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	64.94	12.01	2.03	2.03	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	31.22	1.60	0.00	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	75.34	11.54	2.89	2.24	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	42.83	4.20	1.05	1.05	1.05
nucleus accumbens, adult, pool1	10037-101F1	93.36	17.62	3.66	4.22	4.50
occipital cortex - adult, donor10196	10172-103C1	76.23	16.48	2.06	6.18	4.12
occipital cortex, adult, donor10252	10163-103B1	96.88	7.78	6.17	4.29	5.37
occipital cortex, newborn, donor10223	10355-105E4	44.77	13.10	0.36	1.09	4.73
occipital lobe, adult, donor1	10076-102A4	98.92	14.96	2.36	4.99	2.10
occipital lobe, fetal, donor1	10073-102A1	40.76	10.73	1.72	1.72	2.57
occipital pole, adult, pool1	10036-101E9	93.19	15.14	3.94	3.55	5.20
olfactory region, adult	10195-103E6	70.50	10.51	3.06	5.16	4.59
optic nerve, donor1	10277-104E7	212.11	12.01	10.01	6.00	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	56.04	4.10	1.37	2.28	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	39.57	3.98	0.82	0.27	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.85	3.89	1.02	0.51	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	26.10	3.00	0.92	0.92	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	66.44	7.35	1.76	2.65	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	61.67	13.08	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	36.26	4.24	1.06	0.64	0.42
ovary, adult, pool1	10020-101D2	33.28	4.72	0.52	0.44	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	74.24	9.17	1.47	1.47	0.92
pancreas, adult, donor1	10049-101G4	21.63	1.88	1.88	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	39.69	3.91	1.40	1.40	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	46.17	3.24	1.36	3.07	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	60.11	2.32	0.50	1.32	0.66
paracentral gyrus, adult, pool1	10035-101E8	101.50	16.93	4.39	4.67	7.41
parietal cortex, adult, donor10258	10373-105G4	30.09	6.61	0.00	0.00	3.67
parietal lobe - adult, donor10196	10171-103B9	67.71	9.40	0.00	2.82	4.70
parietal lobe, adult, donor10252	10157-103A4	84.09	8.55	3.14	4.85	3.99
parietal lobe, adult, pool1	10034-101E7	121.25	14.36	5.46	5.73	6.43
parietal lobe, fetal, donor1	10072-101I9	45.58	11.64	2.91	1.94	4.85
parietal lobe, newborn, donor10223	10356-105E5	36.64	12.34	0.37	0.37	2.62
parotid gland, adult	10199-103F1	33.92	1.85	1.23	1.23	0.00
penis, adult	10200-103F2	39.21	6.98	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	16.55	4.83	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	51.28	4.37	1.75	1.89	1.17
pineal gland - adult, donor10196	10179-103C8	63.21	10.32	1.94	4.52	2.58
pineal gland, adult, donor10252	10160-103A7	109.56	9.48	3.55	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	64.59	12.54	3.14	0.63	2.51
pituitary gland - adult, donor10196	10180-103C9	38.45	15.18	1.01	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	85.99	10.94	2.61	1.56	0.52
pituitary gland, adult, donor10258	10378-105G9	52.78	7.66	0.00	0.85	5.11
placenta, adult, pool1	10021-101D3	75.25	8.17	4.62	3.12	4.09
plasma cell leukemia cell line:ARH-77	10840-111E3	12.05	2.38	0.40	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.05	5.29	1.71	1.09	0.47
pons, adult, pool1	10033-101E6	82.37	10.41	3.70	5.16	5.16
postcentral gyrus, adult, pool1	10032-101E5	105.48	15.87	4.36	5.06	6.02
promyelocytes/myelocytes PMC, donor1	12132-128D8	58.56	12.55	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	56.23	4.95	0.58	1.02	0.87
prostate cancer cell line:PC-3	10439-106E7	69.33	6.17	0.91	1.45	1.09
prostate, adult, pool1	10022-101D4	31.38	4.35	1.18	1.27	0.54
putamen, adult, donor10196	10176-103C5	69.40	14.40	3.07	2.12	2.83
putamen, adult, donor10252	10152-102I8	74.51	15.69	1.96	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	7.65	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	40.83	14.98	0.72	2.42	1.69
putamen, newborn, donor10223	10365-105F5	9.00	2.25	0.75	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	44.80	2.91	1.75	1.45	0.87
rectum, fetal, donor1	10067-101I4	44.51	6.95	2.78	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	49.18	7.42	0.42	0.64	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.81	0.41	0.83	0.41	0.41
retina, adult, pool1	10030-101E3	87.47	8.65	2.78	2.98	3.58
retinoblastoma cell line:Y79	10475-106I7	14.55	4.68	0.78	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.37	8.11	0.49	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	57.93	9.84	0.28	0.84	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	56.08	3.03	1.52	0.76	0.76
salivary acinar cells, donor1	11771-123I7	28.65	3.08	0.81	1.29	1.13
salivary acinar cells, donor2	11772-123I8	26.71	2.48	0.41	0.83	1.24
salivary acinar cells, donor3	11773-123I9	34.43	1.99	1.99	2.65	1.99
salivary gland, adult, pool1	10093-102C3	35.46	2.86	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.16	2.95	0.08	0.42	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	16.57	2.47	0.82	0.24	0.24
seminal vesicle, adult	10201-103F3	49.20	6.35	1.06	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.17	5.10	0.97	1.94	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	40.51	6.29	1.51	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	53.19	10.04	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	191.94	11.28	2.96	4.97	2.28
signet ring carcinoma cell line:Kato III	10436-106E4	39.79	2.65	0.88	1.33	2.65
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.19	2.19	0.26	0.77	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	20.57	4.97	0.00	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	36.58	2.76	1.08	0.72	1.20
skeletal muscle, fetal, donor1	10066-101I3	93.47	4.02	3.02	5.03	2.01
skin, adult, donor1	10074-102A2	27.14	13.57	0.00	0.00	13.57
skin, fetal, donor1	10065-101I2	35.35	4.42	1.26	1.89	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	53.70	8.34	4.34	1.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	37.19	1.89	1.58	0.95	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	34.12	12.72	0.19	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	26.54	3.30	0.16	0.33	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	16.57	2.41	0.16	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	49.25	3.27	3.05	1.74	0.44
small intestine, adult, pool1	10024-101D6	33.32	3.22	1.91	0.96	2.51
small intestine, fetal, donor1	10064-101I1	34.64	4.18	1.47	0.98	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	94.37	2.05	1.54	3.59	3.08
smooth muscle, adult, pool1	10048-101G3	26.62	1.81	1.29	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	30.02	1.88	1.61	1.61	2.41
spinal cord - adult, donor10196	10181-103D1	103.00	9.86	3.67	4.82	4.59
spinal cord, adult, donor10252	10159-103A6	66.63	5.91	3.15	1.97	2.37
spinal cord, adult, donor10258	10369-105F9	29.75	6.23	0.00	0.00	3.46
spinal cord, fetal, donor1	10056-101H2	89.04	18.30	7.32	4.88	7.32
spinal cord, newborn, donor10223	10359-105E8	44.54	5.51	0.46	0.92	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	67.51	7.92	1.94	2.84	1.05
spleen, adult, pool1	10025-101D7	38.11	3.74	1.43	0.77	0.77
spleen, fetal, pool1	10044-101F8	41.48	5.24	2.30	0.87	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.60	2.38	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.73	1.90	0.38	1.14	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.64	5.24	1.05	1.40	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	44.96	5.47	1.17	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	26.68	2.81	0.79	0.23	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	32.19	2.97	0.42	1.27	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.50	5.08	0.00	1.27	0.42
stomach, fetal, donor1	10062-101H8	55.53	4.27	0.00	1.07	2.14
submaxillary gland, adult	10202-103F4	25.64	2.85	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	87.65	4.36	4.36	4.57	5.61
substantia nigra, adult, donor10258	10371-105G2	60.52	9.83	1.03	1.03	6.21
substantia nigra, newborn, donor10223	10358-105E7	39.57	5.65	0.00	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	41.27	10.78	0.92	0.92	0.46
temporal lobe, adult, pool1	10031-101E4	109.35	19.75	4.41	4.83	6.87
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	47.72	10.68	3.56	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	30.33	10.11	0.88	0.44	2.20
tenocyte, donor1	11763-123H8	65.63	8.03	2.09	0.70	0.70
tenocyte, donor2	11765-123I1	37.77	5.72	1.14	0.38	1.14
tenocyte, donor3	11768-123I4	54.86	8.90	0.74	1.48	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	33.99	4.76	1.53	0.34	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	33.14	4.47	0.46	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	69.28	6.20	3.72	0.77	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	85.94	11.04	4.19	2.41	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	48.41	7.56	1.13	1.51	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.69	0.65	0.33	0.33	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.89	3.58	0.33	0.33	0.98
testis, adult, pool1	10026-101D8	31.35	5.37	1.29	0.75	0.86
testis, adult, pool2	10096-102C6	28.87	9.92	0.45	0.00	0.00
thalamus - adult, donor10196	10168-103B6	82.80	6.62	2.21	4.42	4.42
thalamus, adult, donor10252	10154-103A1	93.77	4.69	4.38	5.63	6.10
thalamus, adult, donor10258, tech_rep1	10370-105G1	53.89	16.94	0.00	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	52.37	7.74	1.65	3.13	5.60
thalamus, newborn, donor10223	10366-105F6	17.83	4.03	0.58	0.00	0.58
throat, adult	10209-103G2	28.71	2.75	0.75	0.50	1.25
throat, fetal, donor1	10061-101H7	46.92	7.01	1.22	2.74	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	45.11	9.94	0.60	0.60	0.60
thymus, adult, pool1	10027-101D9	15.21	3.68	0.60	0.20	0.10
thymus, fetal, pool1	10043-101F7	22.86	3.64	0.83	0.31	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	59.70	10.24	1.06	1.33	1.60
thyroid carcinoma cell line:TCO-1	10783-110G9	39.95	3.77	0.84	1.40	0.42
thyroid, adult, pool1	10028-101E1	54.87	5.97	1.40	1.59	1.03
thyroid, fetal, donor1	10060-101H6	72.51	10.81	2.64	1.85	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	6.16	0.00	3.08	3.08
tongue, adult	10203-103F5	34.42	2.79	0.70	0.70	1.16
tongue, fetal, donor1	10059-101H5	38.23	5.91	0.39	0.39	0.39
tonsil, adult, pool1	10047-101G2	31.35	3.51	1.70	0.80	0.70
trachea, adult, pool1	10029-101E2	43.35	3.44	1.39	1.88	1.31
trachea, fetal, donor1	10058-101H4	38.08	4.62	1.92	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	54.56	9.92	2.48	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	71.83	6.08	2.13	2.53	2.23
transitional-cell carcinoma cell line:JMSU1	10492-107B6	49.20	6.58	0.94	1.41	0.47
tridermal teratoma cell line:HGRT	10694-109G1	60.88	5.71	1.90	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	73.56	4.91	2.96	2.79	2.20
umbilical cord, fetal, donor1	10057-101H3	33.38	4.17	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	47.09	10.58	0.51	1.19	1.37
uterus, fetal, donor1	10055-101H1	55.80	10.24	3.07	1.54	1.02
vagina, adult	10204-103F6	51.05	3.23	1.29	0.00	0.65
vein, adult	10191-103E2	25.87	5.26	1.32	0.00	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.82	2.14	0.53	0.00	0.00